Literature DB >> 2524234

Regional haemodynamic effect of vasopressin infusion in conscious, unrestrained, Brattleboro rats.

S M Gardiner1, A M Compton, T Bennett.   

Abstract

1. Incremental rates of infusion (0.027-4.0 pmol min-1) of exogenous vasopressin were given for 10 min periods to conscious, Brattleboro (i.e. vasopressin-deficient) rats, which had been chronically instrumented with pulsed Doppler probes and intravascular catheters (to permit assessment of regional haemodynamic changes). 2. There were no significant effects of the two lowest rates of infusion (0.027 and 0.105 pmol min-1) but, after 10 min of vasopressin infusion at 0.313 pmol min-1, superior mesenteric vasoconstriction had occurred unaccompanied by any other changes. Infusion of vasopressin at 0.687 pmol min-1 produced increases in blood pressure and in both mesenteric and hindquarters vascular resistance, but not change in renal vascular resistance or heart rate. These results do not indicate specific interactions between exogenous vasopressin and baroreflex mechanisms to offset the pressor effect of the neuropeptide. 3. The marked bradycardia, hypertension and renal, mesenteric and hindquarters vasoconstriction seen after 10 min infusion of vasopressin at 4.0 pmol min-1 were all abolished 10 min after administration of an antagonist of V1-receptors [+)-(CH2)5Tyr(Et)DAVP); additional antagonism of V2-receptors (with the non-selective antagonist (+)-(CH2)5Tyr(Et)VAVP) had no effects on any measured variable. Hence, the present experiments provide no evidence for important vasodilator effect of vasopressin in conscious, Brattleboro rats.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2524234      PMCID: PMC1854471          DOI: 10.1111/j.1476-5381.1989.tb11935.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

Review 1.  Influence of exogenous vasopressin on baroreflex mechanisms.

Authors:  T Bennett; S M Gardiner
Journal:  Clin Sci (Lond)       Date:  1986-04       Impact factor: 6.124

Review 2.  Endogenous vasopressin and baroreflex mechanisms.

Authors:  S M Gardiner; T Bennett
Journal:  Brain Res       Date:  1986-12       Impact factor: 3.252

3.  Contribution of vasopressin to the maintenance of blood pressure during dehydration.

Authors:  R L Woods; C I Johnston
Journal:  Am J Physiol       Date:  1983-11

4.  Restoration of suppressed baroreflex sensitivity in rats with hereditary diabetes insipidus (Brattleboro rats) by arginine-vasopressin and DDAVP.

Authors:  Y Imai; P L Nolan; C I Johnston
Journal:  Circ Res       Date:  1983-08       Impact factor: 17.367

5.  Cardiovascular actions of vasopressin: baroreflex modulation in the conscious rat.

Authors:  R L Webb; J W Osborn; A W Cowley
Journal:  Am J Physiol       Date:  1986-12

6.  Renal vascular effects of angiotensin II, arginine-vasopressin and bradykinin in rats: interactions with prostaglandins.

Authors:  K G Hofbauer; H Dienemann; P Forgiarini; R Stalder; J M Wood
Journal:  Gen Pharmacol       Date:  1983

7.  Vascular amplifier properties in renovascular hypertension in conscious rabbits. Hindquarter responses to constrictor and dilator stimuli.

Authors:  C E Wright; J A Angus; P I Korner
Journal:  Hypertension       Date:  1987-02       Impact factor: 10.190

8.  Evidence for a vasodilatory effect of vasopressin in the conscious rat.

Authors:  B R Walker
Journal:  Am J Physiol       Date:  1986-07

9.  Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats.

Authors:  S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

10.  Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat.

Authors:  J R Haywood; R A Shaffer; C Fastenow; G D Fink; M J Brody
Journal:  Am J Physiol       Date:  1981-08
View more
  5 in total

1.  Tonic inhibitory control exerted by opioid peptides in the paraventricular nuclei of the hypothalamus on regional hemodynamic activity in rats.

Authors:  Andrée Lessard; Hélène Bachelard
Journal:  Br J Pharmacol       Date:  2002-07       Impact factor: 8.739

2.  Prolonged systemic delivery of peptide drugs by long-circulating liposomes: illustration with vasopressin in the Brattleboro rat.

Authors:  M C Woodle; G Storm; M S Newman; J J Jekot; L R Collins; F J Martin; F C Szoka
Journal:  Pharm Res       Date:  1992-02       Impact factor: 4.200

3.  Neural and humoral control of regional vascular beds via A1 adenosine receptors located in the nucleus tractus solitarii.

Authors:  Joseph M McClure; Donal S O'Leary; Tadeusz J Scislo
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-12-09       Impact factor: 3.619

4.  Stimulation of the ventral tegmental area enhances the effect of vasopressin on blood pressure in conscious rats.

Authors:  M van Den Buuse; R Catanzariti
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

5.  The effect of inhibitors of the L-arginine/nitric oxide pathway on endotoxin-induced loss of vascular responsiveness in anaesthetized rats.

Authors:  G A Gray; C Schott; G Julou-Schaeffer; I Fleming; J R Parratt; J C Stoclet
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.